Institutional portfolio research
Twist Bioscience Corp (TWST) institutional portfolio overlap
Review which current tracker sources report TWST, including tracked institutional 13F portfolios and transparent Mavefund strategy baskets when available. This is partial research data—not complete ownership data or a recommendation.
8 reported 13F managers
0 research strategies
Filing lag applies
Reported Portfolio Sources
Latest tracked institutional filings and Mavefund strategy baskets reporting TWST.
| Tracker | Type | Weight |
|---|---|---|
| ARK Investment Management | 13F manager | 3.0% |
| D. E. Shaw & Co. | 13F manager | 0.05% |
| Citadel Advisors | 13F manager | <0.01% |
| Bridgewater Associates | 13F manager | <0.01% |
| Two Sigma Investments | 13F manager | <0.01% |
| Millennium Management | 13F manager | <0.01% |
| Jane Street Group | 13F manager | <0.01% |
| AQR Capital Management | 13F manager | <0.01% |
Continue TWST Research
Separate delayed portfolio disclosure from current company fundamentals, market signals, and quant-manager context.
Research and Risk Disclosure
This page is for informational research and decision support only. It is not personalized financial advice and does not say that any user should buy or sell a security. 13F investor data reflects last disclosed public filings and may be delayed, incomplete, amended, or no longer current. Strategy returns are historical model output or live tracking only when explicitly marked live. Review benchmark, time period, rebalancing frequency, data assumptions, fees, slippage, drawdown, and survivorship-bias handling before relying on any performance comparison.